Revolutionary Eye-Tracking Technology
RightEye (righteye.com) earns a Brand Analyzer score of 72 out of 100, placing it in the Brand-Ready tier among Healthcare brands, Technology brands. Among 2305 Healthcare brands analyzed, RightEye ranks in the 73rd percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 90/100, Digital Presence 82/100, Visual Identity 96/100, Messaging Clarity 95/100, Trust Foundation 74/100, AI Discoverability 81/100, Brand Authority 21/100.
RightEye is a healthcare technology company that develops eye-tracking systems for eye care providers. Its core product, the FDA-cleared RightEye Vision System, records and analyzes eye movements to identify visual tracking impairments. The company offers the first automated sensorimotor exam built on over 30 years of science. RightEye targets eye care providers and medical practices, positioning its technology as a tool to improve patient outcomes and increase practice revenue.
| Brand Name | RightEye |
|---|---|
| Domain | righteye.com |
| Industry | Healthcare, Technology |
| Main Competitors | Neurolens, Eyecare Plus, SMI (SensoMotoric Instruments), Tobii, Videonystagmography by Interacoustics |
Moz Domain Authority 38/100 vs category average 29 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #3,063,811 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Life is not static and 20/20 vision is not enough. A life in motion requires dynamic vision. RightEye" (Meta description: 18 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt mentions GPTBot, ClaudeBot, Google-Extended - all allowed - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on Facebook, LinkedIn, Instagram, YouTube, GitHub; no detected presence on X (Twitter) - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
RightEye scores 30/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
RightEye has a weak AI-visibility profile at 30/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (55/100) and its weakest is visibility (15/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #3,063,811 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 38/100 and thin schema.org structured data.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
RightEye's main competitors include Neurolens, Eyecare Plus, SMI (SensoMotoric Instruments), Tobii, Videonystagmography by Interacoustics. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: RightEye official site
Popular alternatives to RightEye include Neurolens, Eyecare Plus, SMI (SensoMotoric Instruments), Tobii, Videonystagmography by Interacoustics. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: RightEye official site
RightEye's primary product is the FDA-cleared RightEye Vision System, an eye-tracking platform that enables automated sensorimotor examinations. The system records and analyzes eye movements to identify visual tracking impairments. It is positioned for use by eye care providers and medical practices. The company describes its offering as built on revolutionary eye-tracking technology and grounded in over 30 years of scientific research. No additional specific product lines or service tiers are detailed in the available facts.
Sources: RightEye official site
RightEye has limited AI-search visibility, scoring 30/100 on Brand Analyzer's AI visibility composite (visibility 15, trust 33, recommendation 55). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: RightEye official site
RightEye records, views, and analyzes indiscernible eye movements to support eye care providers in identifying and addressing visual tracking impairments. Using its FDA-cleared RightEye Vision System, the company delivers automated sensorimotor exams powered by revolutionary eye-tracking technology. The system is built on more than 30 years of science and is designed to give eye care practitioners actionable data to improve patient care and increase practice revenue.
Sources: RightEye official site
RightEye is a healthcare technology company that provides an FDA-cleared eye-tracking system designed for eye care providers. It operates at the intersection of healthcare and technology, offering tools to record, view, and analyze eye movements that are typically indiscernible to the naked eye. The company's platform is described as the first automated sensorimotor exam system, backed by over 30 years of scientific research, and is intended to help practitioners identify and address visual tracking impairments in patients.
Sources: RightEye official site
RightEye and Neurolens are competitors in Healthcare. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: RightEye official site
RightEye scores 55/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: RightEye official site
RightEye's target audience consists of eye care providers and medical practices. The system is specifically designed to support clinicians in identifying and addressing visual tracking impairments in their patients. By providing automated sensorimotor exam capabilities, RightEye aims to enhance diagnostic workflows for practitioners while also offering a potential means to increase practice revenue. The known facts do not specify particular specialties beyond general eye care providers.
Sources: RightEye official site
RightEye is known for offering the first automated sensorimotor exam using revolutionary eye-tracking technology. Its flagship product, the FDA-cleared RightEye Vision System, is distinguished by its ability to capture and analyze fine eye movements that are not visible to the human eye. The company emphasizes that standard 20/20 vision testing is insufficient and promotes the concept of dynamic vision - the idea that life in motion requires more comprehensive visual assessment.
Sources: RightEye official site
RightEye can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: RightEye official site
Ranked closest to RightEye: RegDesk (72/100), Aviary Health (72/100), Instem (72/100), RTI Group (72/100).
A step up - brands to learn from: Zipline (81/100), Zimmer Biomet (81/100).
Category leader: Dassault Systèmes (95/100).